The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Time-Dependent Changes in Matrix Metalloproteinase Activity and Expression During the Progression of Congestive Heart Failure: Relation to Ventricular and Myocyte Function
Open accessAbstract
Abstract —The development of congestive heart failure (CHF) is associated with left ventricular (LV) dilation and myocardial remodeling. However, fundamental mechanisms that contribute to this remodeling process with the progression of CHF remain unclear. The matrix metalloproteinases (MMPs) have been demonstrated to play a significant role in tissue remodeling in a number of pathological processes. The present project tested the hypothesis that the LV dilation and remodeling during the progression of CHF is associated with early changes in MMP expression and zymographic activity. LV and myocyte function, collagen content, and MMP expression and zymographic activity were serially measured during the progression of CHF caused by pacing-induced supraventricular tachycardia (SVT) in pigs. After 7 days of SVT, LV end-diastolic dimension and myocyte length both increased by 15% from control values, and LV fractional shortening fell by 20%. At the level of the myocyte, percent shortening fell by 16% after 7 days of SVT, with no change in the steady-state velocity of shortening. Longer durations of SVT caused progressive LV dilation, LV pump failure, and myocyte contractile dysfunction. Specifically, 21 days of SVT resulted in a >50% increase in LV dimension, a 56% fall in LV fractional shortening, and a 33% decline in myocyte velocity of shortening. The decline in LV and myocyte function with 21 days of SVT was accompanied by signs and symptoms of CHF. Thus, SVT causes time-dependent changes in LV geometry and function and the subsequent development of CHF. LV myocardial collagen content and confluence fell by >25% after 7 days of SVT and were accompanied by an 80% increase in LV myocardial MMP zymographic activity against the substrate gelatin. After 14 days of SVT, total LV myocardial collagen content was reduced by 24%, and LV myocardial MMP zymographic activity increased by >100% from control values. Interstitial collagenase (MMP-1), stromelysin (MMP-3), and 72-kD gelatinase (MMP-2) were increased by ≈2-fold after 7 days of SVT. LV MMP zymographic activity and abundance remained elevated with longer durations of SVT. The results of the present study demonstrated that in this model of CHF, early changes in LV myocardial MMP zymographic activity and protein levels occurred with the initiation and progression of LV dilation and dysfunction. These findings suggest that an early contributory mechanism for the initiation of LV remodeling that occurred in this model of developing CHF is enhanced expression and potentially increased activity of LV myocardial MMPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burnette, W. N. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90281-5 · Cited by 8,429
Matrix metalloproteinases and their inhibitors in connective tissue remodeling
Woessner, J. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.8.1850705 · Cited by 3,282
Galis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,539
Stereological Methods. Practical methods for biological morphometry
Weibel, E. R. (1979) · Academic Press eBooks · Cited by 1,994
Heussen, C., & Dowdle, E. B. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90338-3 · Cited by 1,973
Kelley, W. N. (1985) · Virtual Defense Library (Ministerio de Defensa) · Cited by 1,670
Practical methods for biological morphometry
Weibel, E. R. (1979) · Academic Press eBooks · Cited by 1,563
Bristow, M. R., Ginsburg, R., Umans, V, Fowler, M., Minobe, W., Rasmussen, R., Zera, P., Menlove, R., Shah, P., & Jamieson, S. (1986) · Circulation Research · doi:10.1161/01.res.59.3.297 · Cited by 1,327
Matrix Metalloproteinases and Cardiovascular Disease
Dollery, C. M., McEwan, J. R., & Henney, A. M. (1995) · Circulation Research · doi:10.1161/01.res.77.5.863 · Cited by 864
Ross, J. (1976) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(76)90021-9 · Cited by 654
Cited by
Left Ventricular Hypertrophy: Pathogenesis, Detection, and Prognosis
Lorell, B. H., & Carabello, B. A. (2000) · Circulation · doi:10.1161/01.cir.102.4.470 · Cited by 1,232
Oxidative stress and heart failure
Tsutsui, H., Kinugawa, S., & Matsushima, S. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00554.2011 · Cited by 1,231
Spinale, F. G. (2007) · Physiological Reviews · doi:10.1152/physrev.00012.2007 · Cited by 1,120
Self-citationIorga, A., Cunningham, C. M., Moazeni, S., Ruffenach, G., Umar, S., & Eghbali, M. (2017) · Biology of Sex Differences · doi:10.1186/s13293-017-0152-8 · Cited by 914
Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target?
Senoner, T., & Dichtl, W. (2019) · Nutrients · doi:10.3390/nu11092090 · Cited by 868
Matrix Metalloproteinases: Regulation and Dysregulation in the Failing Heart
Spinale, F. G. (2002) · Circulation Research · doi:10.1161/01.res.0000013290.12884.a3 · Cited by 726
Self-citationSiwik, D. A., Pagano, P. J., & Colucci, W. S. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.1.c53 · Cited by 674
Creemers, E. E. J. M., Cleutjens, J. P. M., Smits, J. F. M., & Daemen, M. J. A. P. (2001) · Circulation Research · doi:10.1161/hh1501.094396 · Cited by 598
Cardiac Fibrosis in Patients With Atrial Fibrillation
Dzeshka, M. S., Lip, G. Y. H., Snezhitskiy, V., & Shantsila, E. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.1313 · Cited by 552
The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury
Kriegel, A. J., Liu, Y., Fang, Y., Ding, X., & Liang, M. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00141.2011 · Cited by 533
“In dilated cardiomyopathy the left ventricle is dilated and becomes more compliant while the activity of extracellular matrix degrading matrix metalloproteinase increases (7, 12, 82, 87).”
BackgroundKhan, R., & Sheppard, R. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02336.x · Cited by 501
Spinale, F. G., Coker, M. L., Heung, L. J., Bond, B. R., Gunasinghe, H. R., Etoh, T., Goldberg, A. T., Zellner, J. L., & Crumbley, A. J. (2000) · Circulation · doi:10.1161/01.cir.102.16.1944 · Cited by 476
Self-citationPathophysiology of chronic heart failure
Packer, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)90405-r · Cited by 473
Rohde, L. E., Ducharme, A., Arroyo, L. H., Aikawa, M., Sukhova, G. H., Lopez-Anaya, A., McClure, K. F., Mitchell, P. G., Libby, P., & Lee, R. T. (1999) · Circulation · doi:10.1161/01.cir.99.23.3063 · Cited by 437
Matrix Metalloproteinase-2 Contributes to Ischemia-Reperfusion Injury in the Heart
Cheung, P.-Y., Sawicki, G., Wozniak, M., Wang, W., Radomski, M. W., & Schulz, R. (2000) · Circulation · doi:10.1161/01.cir.101.15.1833 · Cited by 431
Animal Models of Cardiovascular Diseases
Zaragoza, C., Gomez-Guerrero, C., Martin-Ventura, J. L., Blanco-Colio, L., Lavin, B., Mallavia, B., Tarin, C., Mas, S., Ortiz, A., & Egido, J. (2011) · BioMed Research International · doi:10.1155/2011/497841 · Cited by 402
Arrhythmia-Induced Cardiomyopathies
Gopinathannair, R., Etheridge, S. P., Marchlinski, F. E., Spinale, F. G., Lakkireddy, D., & Olshansky, B. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.038 · Cited by 385
Self-citationMitochondrial oxidative stress and dysfunction in myocardial remodelling
Tsutsui, H., Kinugawa, S., & Matsushima, S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn280 · Cited by 377
Segura, A. M., Frazier, O. H., & Buja, L. M. (2014) · Heart Failure Reviews · doi:10.1007/s10741-012-9365-4 · Cited by 371
Timmers, L., Sluijter, J. P. G., van Keulen, J. K., Hoefer, I. E., Nederhoff, M. G. J., Goumans, M.-J., Doevendans, P. A., van Echteld, C. J. A., Joles, J. A., Quax, P. H., et al. (2008) · Circulation Research · doi:10.1161/circresaha.107.158220 · Cited by 344
Matsumura, S.-I., Iwanaga, S., Mochizuki, S., Okamoto, H., Ogawa, S., & Okada, Y. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522304 · Cited by 339
Intramyocardial Fibroblast Myocyte Communication
Kakkar, R., & Lee, R. T. (2010) · Circulation Research · doi:10.1161/circresaha.109.207456 · Cited by 333
Li, Y. Y., Feng, Y. Q., Kadokami, T., McTiernan, C. F., Draviam, R., Watkins, S. C., & Feldman, A. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12746 · Cited by 324
Spinale, F. G., Coker, M. L., Krombach, S. R., Mukherjee, R., Hallak, H., Houck, W. V., Clair, M. J., Kribbs, S. B., Johnson, L. L., Peterson, J. T., et al. (1999) · Circulation Research · doi:10.1161/01.res.85.4.364 · Cited by 323
Self-citationKinugawa, S., Tsutsui, H., Hayashidani, S., Ide, T., Suematsu, N., Satoh, S., Utsumi, H., & Takeshita, A. (2000) · Circulation Research · doi:10.1161/01.res.87.5.392 · Cited by 323
Hayashidani, S., Tsutsui, H., Ikeuchi, M., Shiomi, T., Matsusaka, H., Kubota, T., Imanaka-Yoshida, K., Itoh, T., & Takeshita, A. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00207.2003 · Cited by 315
Hayashidani, S., Tsutsui, H., Shiomi, T., Suematsu, N., Kinugawa, S., Ide, T., Wen, J., & Takeshita, A. (2002) · Circulation · doi:10.1161/hc0702.104164 · Cited by 308
Peterson, J. T., Hallak, H., Johnson, L., Li, H., O’Brien, P. M., Sliskovic, D. R., Bocan, T. M. A., Coker, M. L., Etoh, T., & Spinale, F. G. (2001) · Circulation · doi:10.1161/01.cir.103.18.2303 · Cited by 301
Self-citationBrain Natriuretic Peptide Is Produced in Cardiac Fibroblasts and Induces Matrix Metalloproteinases
Tsuruda, T., Boerrigter, G., Huntley, B. K., Noser, J. A., Cataliotti, A., Costello-Boerrigter, L. C., Chen, H. H., & Burnett, J. C. (2002) · Circulation Research · doi:10.1161/01.res.0000046234.73401.70 · Cited by 301
Peterson, J. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00029-8 · Cited by 298
Organization of fibroblasts in the heart
Goldsmith, E. C., Hoffman, A., Morales, M. O., Potts, J. D., Price, R. L., McFadden, A., Rice, M., & Borg, T. K. (2004) · Developmental Dynamics · doi:10.1002/dvdy.20095 · Cited by 289
Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress
Angsutararux, P., Luanpitpong, S., & Issaragrisil, S. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/795602 · Cited by 288
Disruption of the myocardial extracellular matrix leads to cardiac dysfunction
Kim, H. E., Dalal, S. S., Young, E., Legato, M. J., Weisfeldt, M. L., & D’Armiento, J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8040 · Cited by 281
Johnson, L. L., Dyer, R., & Hupe, D. J. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80122-1 · Cited by 270
Li, Y. Y., Feng, Y., McTiernan, C. F., Pei, W., Moravec, C. S., Wang, P., Rosenblum, W., Kormos, R. L., & Feldman, A. M. (2001) · Circulation · doi:10.1161/hc3501.095215 · Cited by 270
Metabolic and Vascular Effect of the Mediterranean Diet
Tuttolomondo, A., Simonetta, I., Daidone, M., Mogavero, A., Ortello, A., & Pinto, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194716 · Cited by 269
Siwik, D. A., & Colucci, W. S. (2004) · Heart Failure Reviews · doi:10.1023/b:hrev.0000011393.40674.13 · Cited by 259
Mitochondria and cardiovascular diseases-from pathophysiology to treatment
Siasos, G., Tsigkou, V., Kosmopoulos, M., Theodosiadis, D., Simantiris, S., Tagkou, N. M., Tsimpiktsioglou, A., Stampouloglou, P. K., Oikonomou, E., Mourouzis, K., et al. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.06.21 · Cited by 245
“For example, in a model of pacinginduced supraventricular tachycardia in pigs it was demonstrated that MMP 1, 2 and 3 induce left ventricle dysfunction and dilation of left ventricle at 7 days (153).”
BackgroundSPALLAROSSA, P., ALTIERI, P., GARIBALDI, S., GHIGLIOTTI, G., BARISIONE, C., MANCA, V, FABBI, P., BALLESTRERO, A., BRUNELLI, C., & BARSOTTI, A. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.08.009 · Cited by 182
Cardiac remodeling and failure
Fedak, P. W. M., Verma, S., Weisel, R. D., & Li, R.-K. (2005) · Cardiovascular Pathology · doi:10.1016/j.carpath.2005.01.005 · Cited by 120
Wohlgemuth, S. E., Calvani, R., & Marzetti, E. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.03.007 · Cited by 97
Early induction of matrix metalloproteinase-9 transduces signaling in human heart end stage failure
Moshal, K. S., Tyagi, N., Moss, V., Henderson, B., Steed, M., Ovechkin, A., Aru, G. M., & Tyagi, S. C. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00501.x · Cited by 61
“Recent studies have also demonstrated that MMP-9 content and activity are increased in the failing human heart [14–17] and MMPs are implicated in the progression of ventricular dilation and the development of heart failure [18–20].”
BackgroundBiały, D., Wawrzyńska, M., Bil-Lula, I., Krzywonos-Zawadzka, A., Sapa-Wojciechowska, A., Arkowski, J., Woźniak, M., & Sawicki, G. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370218779773 · Cited by 11
Metadata
- Authors
- Spinale, F. G., Coker, M. L., Thomas, C. V., Walker, J. D., Mukherjee, R., & Hebbar, L.
- Venue
- Circulation Research
- Published
- 1998-03-09
- Volume
- 82
- Issue
- 4
- Pages
- 482-495
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2164160223
- Cited by
- 372
- References
- 57
- FWCI
- 13.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.